Sanofi says Lemtrada helps MS patients in study
by on Oct.22, 2011, under Health and Fitness
French drugmaker Sanofi said on Saturday that its experimental multiple sclerosis drug Lemtrada worked better than an older drug sold by competitor Merck KGaA at keeping patients free from relapses.
View full post on Yahoo! Health News
